Increased serum levels of cartilage oligomeric matrix protein in patients with psoriasis vulgaris: A marker for unknown peripheral joint involvement?

Clinical and Experimental Rheumatology

Volumn 26, Issue 6, 2008, Pages 1087-1090

  Skoumal, Martin ^a,b   Haberhauer, G ^a   Fink, A ^c   Steiner, A ^c   Klingler, A ^d   Varga, F ^b   Klaushofer, K ^b  

^a DANUBE UNIVERSITY KREMS   (Austria)

^b HANUSCH HOSPITAL   (Austria)

^c WILHELMINEN HOSPITAL   (Austria)

^d UNIVERSITY HOSPITAL INNSBRUCK   (Austria)

Author keywords

Cartilage oligomeric matrix protein; Cartilage turnover; Psoriasis vulgaris; Psoriatic arthritis

Indexed keywords

C REACTIVE PROTEIN; CARTILAGE OLIGOMERIC MATRIX PROTEIN;

AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATION; JOINT EXAMINATION; JOINT SWELLING; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS VULGARIS; PSORIATIC ARTHRITIS;

ARTHRITIS, PSORIATIC; BIOLOGICAL MARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; JOINTS; MALE; MIDDLE AGED; PSORIASIS;

EID: 59149096061     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. JONES SM, ARMASOJ, COHN M et al.: Psoriatic arthritis: outcome of disease subsets and relationship of joint disease to nail and skin diseases. Br J Rheumatol 1994; 33: 834-9.
2. ESPINOZA LR, VASEY FB, ESPINOZA CG et al.: Vascular changes in psoriatic synovium. A light and electron microscopic study. Arthritis Rheum 1982; 25: 677-84.
3. OLDBERG A, ANTONSSON P, LINDBLOM K, HEINEGAARD D: COMP (cartilage oligomeric matrix protein) is structurally related to the thrombospondins. J Biol Chem 1992; 267: 22346-50.
4. SAXNE T, HEINEGARD D: Involvement of nonarticular cartilage, as demonstrated by release of a cartilage-specific protein, in rheumatoid arthritis. Arthritis Rheum 1989; 32: 1080-6.
5. HEDBOM E, ANTONSSON P, HJERPE A et al.: Cartilage matrix proteins. An acidic oligomeric protein (COMP) detected only in cartilage. J Biol Chem 1992; 267: 6132-6.
6. DI CESARE PE, CARLSON CS, STOLLERMANN ES, HAUSER N, TULLI H, PAULSSON M: Increased degradation and altered tissue distribution of cartilage oligomeric matrix protein in human rheumatoid and osteoarthritic cartilage. J Orthop Res 1996; 14: 946-55.
7. DI CESARE PE, FANG C, LESLIE MP et al.: Localization and expression of cartilage oligomeric matrix protein by human rheumatoid and osteoarthritic synovium and cartilage. J Orthop Res 1999; 17: 437-45
8. WOLLHEIM FA, EBERHARDT KB, JOHNSON U, SAXNE T: HLA DRB1 typing and cartilage oligomeric matrix protein (COMP) as predictors of joint destruction in recent-onset rheumatoid arthritis. Brit J Rheumatol 1997; 36: 847-9.
9. DI CESARE PE, FANG C, LESLIE MP, TULLI H, PERRIS R, CARLSON CS: Expression of cartilage oligomeric matrix protein (COMP) by embryonic and adult osteoblasts. J Orthop Res 2000; 18: 713-20.
10. FORSLIND K, EBERHARDT K, JONSSON A, SAXNE T: Increased serum concentrations of cartilage oligomeric matrix protein. A prognostic marker in early rheumatoid arthritis. Br J Rheumatol 1992; 31: 593-8.
11. KUHNE SA, NEIDHART M, EVERSON MP et al.: Persistent high serum levels of cartilage oligimeric matrix protein in a subgroup of patients with traumatic knee injury. Rheumatol Int 1998; 18: 21-5.
12. MANSSON B, GEBOREK P, SAXNE T: Cartilage and bone macromolecules in knee joint synovial fluid in rheumatoid arthritis: Relation to development of knee or hip joint destruction. Ann Rheum Dis 1997; 56: 91-6.
13. MANSSON B, GÜLFEA, GEBOREK P, HEINEGARD D, SAXNE T: Release of cartilage and bone macromolecules into synovial fluid: Differences between psoriatic arthritis and rheumatoid arthritis. Ann Rheum Dis 2001; 60: 27-31.
14. WOLLHEIM FA: Markers of disease in rheumatoid arthritis. Cur Opin Rheumatol 2000; 12: 200-4.
15. SKOUMAL M, HABERHAUER G, FEYERTAG J, KITTL EM, BAUER K, DUNKY A: Serum levels of cartilage oligomeric matrix protein (COMP) are elevated in rheumatoid arthritis, but not in inflammatory rheumatic diseases as psoriatic arthritis, reactive arthritis, Raynaud's syndrome, scleroderma, systemic lupus erythematosus, vasculitis and Sjögren's syndrome. Arthritis Res Ther 2004; 6: 73-4.
16. SKOUMAL M, KOLARZ G, KLINGLER A: Serum levels of Cartilage Oligomeric Matrix Protein (COMP): A predicting factor and a valuable parameter for disease management in rheumatoid arthritis. Scand J Rheumatol 2003; 32: 156-61.
17. VALLBRACHT I, GRUBER R, SIWY M, SCHATTENKIRCHNER M, KELLNER H: Prognostische Wertigkeit von COMP (Cartilage Oligomeric Matrix Protein) bei Patienten mit rheumatischen Erkrankungen. Z Rheumatol 2001; 60: S.1: I/57.
18. MANSSON B, CAREY D, ALINI M et al.: Cartilage and bone metabolism in rheumatoid arthritis. Differences between rapid and slow progression of disease identified by serum markers of cartilage metabolism. J Clin Invest 1995; 95: 1071-77.
19. DI CESARE PE, CARLSON CS, STOLLERMANN ES, CHEN FS, LESLIE M, PERRIS R: Expresssion of cartilage oligomeric matrix protein by human synovium. FEBS Letters 1997; 412: 249-52.
20. HUMMEL KM, NEIDHART M, VILJM V et al.: Analysis of cartilage oligomeric matrix protein (COMP) in synovial fibroblasts and synovial fluids. Br J Rheumatol 1998; 37: 721-8.
21. LARSSON E, MUSSENER A, HEINEGARD D, KLARESKOG L, SAXNE T: Increased serum levels of cartilage oligomeric matrix protein and bone sialoprotein in rats with collagen arthritis. Br J Rheumatol 1997; 36: 1258-61.
22. FITZGERALD O, KANE D: Clinical, immunopathogenic, and therapeutic aspects of psoriatic arthritis. Curr Opin Rheumatol 1997; 9: 295-301.
23. GLADMAN DD, MEASE PJ, CIFALDI MA, PERDOK RJ. SASSO E, MEDICH J: Adalimumab improves joint- and skin-related functional impairment in patients with psoriatic arthritis: Patient- reported outcomes of the Adalimumab Effectiveness in Psoriatic Arthritis Trial (ADEPT). Ann Rheum Dis 2006; 66: 163-8.
24. MARTI C, NEIDHART M, GERBER T, HAUSER N, MICHEL BA, HÄUSELMANN HJ: Cartilage Oligomeric Matrix Protein (COMP): Die Rolle eines nichtkollagenen Knorpel-Matrix-Proteins als Marker der Krankheitsaktivität und Gelenkszerstörung bei Patienten mit rheumatoider Arthritis und Arthrose. Z Rheumatol 1999; 58: 79-87.
25. NEIDHART M, HAUSER N, PAULSSON M, DICESARE PE, MICHEL BA, HÄUSELMANN HJ: Small fragments of cartilage oligomatrix protein in synovial fluid and serum as markers for cartilage degradation. Br J Rheumatol 1997; 36: 1151-60.
26. NEIDHART M, MÜLLER-LADNER U, FREY W et al.: Increased serum levels of non-collagenous matrix proteins (cartilage oligomeric matrix protein and melanoma inhibitory activity) in marathon runners. Osteoarthritis Cartilage 2000; 8: 222-9.
27. PETERSON IF, SANDQVIST L, SVENSSON B, SAXNE T: Cartilage markers in synovial fluid in symptomatic knee osteoarthritis. Ann Rheum Dis 1997; 56: 64-7.
28. PETERSON IF, BOEGARD T, SVENSSON B, HEINEGARD D, SAXNE T: Changes in cartilage and bone metabolism identified by serum markers in early osteoarthritis of the knee joint. Br J Rheumatol 1998; 37: 46-50.
29. RECKLIES AD, BAILLARGEON L, WHITE C: Regulation of cartilage oligomeric matrix protein synthesis in human synovial cells and articular chondrocytes. Arthritis Rheum 1998; 41:997-1006.
30. FEX E, EBERHARD K, SAXNE T: Tissue-derived macromolecules and markers of inflammation in serum in early rheumatoid arthritis: Relationship to develop-ment of joint destruction in hands and feet. Br J Rheumatol 1997; 36: 847-9.
31. DODGE GR, HAWKINS D, BOESLER E, SAKAI L, JIMENEZ SA: Production of cartilage oligomeric matrix protein (COMP) by cultured human dermal and synovial fibroblasts. Osteoarthritis Cartilage 1998; 6: 435-40.
32. GANU V, GOLDBERG R, PEPPARD J et al.: Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors. Arthritis Rheum 1998; 41: 2143-51.
33. FARINA G, LEMAIRE R, KORN JH, WIDOM RL: Cartilage oligomeric matrix protein is overexpressed by scleroderma dermal fibroblasts. Matrix Biol 2006; 25: 213-22.
34. MOLL JMH, WRIGHT V: Psoriatic arthritis. Semin Arthritis Rheum 1973; 3: 55-78.
35. GOMEZ-BARRENA E, LINDROOS L, CEPONIS A et al.: Cartilage oligomeric matrix protein (COMP) is modified by intra-articular liposomal clodronate in an experimental model of arthritis. Clin Exp Rheumatol 2006; 24: 622-8
36. JUNG YO, DO JH, KANG HJ, YOO SA, YOON CH, KIM HA, CHO CS, KIM WU: CORRELATION of sonographic severity with biochemical markers of synovium and cartilage in knee osteoarthritis patients. Clin Exp Rheumatol 2006; 24: 253-9.